Product Locator: Spring Gifts for IPC Personnel and Their Families
February 1st 2024Whether it's Valentine's, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
CSL's ARCT-154: The World’s First Self-Amplifying mRNA Vaccine Approved for COVID-19 in Adults
February 1st 2024CSL achieves a global milestone as Japan approves ARCT-154, the first sa-mRNA COVID-19 vaccine, showcasing CSL's commitment to innovation, efficacy, and prolonged protection against variants. Jonathan Edelman, MD, senior VP of CSL Vaccine’s Innovation Unit, speaks with ICT.
Infection Control Today's Round Table Focuses on Burnout: Recognition, Stigma, and Prevention
January 30th 2024Frontline infection preventionists (IPs) face burnout due to challenges in public health. This Round Table on IP Burnout discusses strategies to prevent and address this critical issue. The IPs emphasize the importance of understanding burnout, recognizing signs, addressing stigma, and implementing multilayered prevention strategies for both individuals and organizations.
Balancing Act: Insights From an Infection Preventionist, Mother, and Volunteer
January 30th 2024Jill E. Holdsworth, MS, CIC, FAPIC, NREMT, CRCST, prevention manager, discusses the challenges of balancing work, family, and volunteering, emphasizing the importance of prioritizing self-care and personal interests.
Infection Prevention in Low-Resource Settings: Two Infection Preventionists Consult in East Africa
January 29th 2024Infection preventionists Heather Saunders and Stephanie Mayoryk's journey to East Africa emphasizes the positive impact of infection prevention efforts in low-income countries. Despite challenges, their experience encourages IPs to engage globally, fostering hope and passion for providing excellent patient care.
Navigating Sterility: FDA's Comprehensive Guidelines on 510(k) Submissions for Sterile Devices
January 22nd 2024FDA's latest guidance on 510(k) submissions for sterile devices outlines priorities and updates for traditional and novel sterilization methods, ensuring a comprehensive approach to information inclusion.
Nurturing the Spirit: A Look Into the Well-Being of Infection Preventionists
January 19th 2024In the dynamic realm of infection prevention, professionals face both the potential for impactful contributions and the risk of burnout. The delicate balance between the highs and lows prompts an exploration into factors influencing the well-being of infection preventionists.
Revolutionizing Patient Engagement: Healthvana's AI-Powered Approach
January 18th 2024Ramin Bastani, Healthvana's CEO, unveils the groundbreaking AI Navigator/Chatbot enhancing patient engagement in sexual health clinics. The HIPAA-compliant tool streamlines inquiries boosts efficiency and prioritizes patient benefits.
Insights From the Clean Index Survey: Navigating Challenges in the Cleaning Industry
January 17th 2024Clorox Pro's Clean Index Survey uncovers burnout and confidence challenges in cleaning professionals. The insights guide the industry towards solutions, emphasizing support and training for a resilient cleaning workforce.
Advancing Diabetic Foot Care: A Conversation With Gary M. Rothenberg, DPM
January 17th 2024Explore diabetic foot care insights with Gary M. Rothenberg, DPM, Director of Medical Affairs at Podimetrics. Learn about prevention, remote monitoring, and the multidisciplinary approach to mitigate the risks of amputations.
AI-Driven Predictive Analytics: Transforming Drug Development
January 15th 2024VeriSIM Life, a health care technology company, utilizes AI to forecast drug candidates' clinical success, accelerating development and reducing costs. Founder and CEO, Jo Varshney, discusses successful applications, challenges, privacy standards, and advice for leveraging AI in health care operations.
Revolutionary Antibiotic-Resistant Gonorrhea Treatment: A Possible Breakthrough with Recce 327
January 11th 2024With gonorrhea's rising antibiotic resistance, Recce 327 by Recce Pharmaceuticals emerges as a game-changer, showing 99% efficacy in preclinical trials and promising potential against antibiotic-resistant bacteria globally.
SHEA/IDSA/APIC Answer to Diekema, et al, Study on Prevention of MRSA Infection and Transmission
January 9th 2024Society for Healthcare Epidemiology of America/Infectious Diseases Society of America/Association for Professionals in Infection Control and Epidemiology answer Diekema, et al, about MRSA prevention strategies.